Photo from Aaron Goodman/X
Jul 16, 2024, 23:44
Aaron Goodman: Oncology Board Review
Aaron Goodman shared a post on X:
”Oncology Board Review!
A 70 year old with metastatic pancreatic cancer is being treated with gemcitabine+Abraxane achieving a partial response (PR).
On cycle 5 he develops severe fatigue.
CBC:
- Hb: 6.5
- WBC: 3.0
- Plt: 40
Other Labs:
- Cr: 2.5 (baseline 1.3)
- LDH: 400
- Bili: 2.0
What’s going on?”
Source: Aaron Goodman/X
Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 11:10
Nov 13, 2024, 10:59
Nov 13, 2024, 10:54
Nov 13, 2024, 10:45